Deep Medicine Acquisition Corp. (DMAQ)
2.96
-5.43 (-64.72%)
Jan 31, 2024, 9:00 PM - Market open
-64.72% (1D)
| Bid | n/a |
| Market Cap | 12.9M |
| Revenue (ttm) | 90K |
| Net Income (ttm) | -1.55M |
| EPS (ttm) | -0.13 |
| PE Ratio (ttm) | -22.76923076923077 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 73,881 |
| Avg. Volume (20D) | 14,214 |
| Open | 7.54 |
| Previous Close | 8.39 |
| Day's Range | 2.96 - 7.69 |
| 52-Week Range | 2.96 - 19.91 |
| Beta | 0.02 |
About DMAQ
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York....
Industry Shell Companies
Sector Financial Services
IPO Date Dec 2, 2021
Employees 2
Stock Exchange NASDAQ
Ticker Symbol DMAQ